RE: Detail in the RNS...Alaways Important !27 Aug 2025 16:10
If raise was just for negotiation leverage, you’d do it after assays.
They’ve done it now to hedge against bad assay result and ensure their next few years of fees.
Cynical of them, yes. Criminal, unusually for them, no.
Does it really matter, no. We could have raised more on less dilution and have a stronger hand. But in the end, the assays talk.
Problem now is boredom without news. Though this share does constantly surprise me!